Cannabis Stock Research and Market Analysis
Institutional-grade cannabis stock research, cannabis market analysis, and cannabis sector outlook covering the full 494-ticker universe. Analyst consensus, price targets, valuation multiples, thematic deep dives, and macro overlays from the CIN Research Desk.
Cannabis stock research modules
- Cannabis analyst coverage: Aggregated sell-side ratings, 12-month price targets, and consensus revisions across the universe (see analyst)
- Cannabis financials: Revenue, EBITDA, margins, balance sheet metrics, and EBITDA multiples from SEC filings (see financials)
- Cannabis market analysis: Daily briefs, weekly wraps, and thematic write-ups on sector rotations and catalysts (see insights)
- Cannabis sector outlook: Forward views on regulatory, macro, and fundamentals via Future Lens (see Future Lens)
- Cannabis chart book: Weekly PDF with sector medians, regional performance, and top movers (see chartbook)
What CIN research covers
The CIN Research Desk publishes cannabis market analysis on three timescales. Daily coverage arrives via the Open, Midday, and Close briefs: same-day price action, catalysts, and analyst moves. Weekly coverage lands in the chart book: sector medians, regional performance, top gainers and decliners, and methodology notes. Long-form thematic research runs in Insights and Future Lens: sector rotations, regulatory scenarios, valuation frameworks, and cross-market comparisons.
Methodology and sourcing
Every research output cites primary sources: SEC filings for financials, exchange filings for cross-border listings, EODHD for prices, Finnhub for analyst consensus, and the CIN reference database for the ticker universe. Methodology is transparent, version-controlled, and documented at methodology. Numbers are cite-ready.
Access institutional-grade cannabis research
Long-form thematic analysis, valuation frameworks, and sector deep dives from the CIN Research Desk.
Read the latest research →Frequently asked questions
What is cannabis stock research?
Cannabis stock research is analytical coverage of publicly traded cannabis companies covering fundamentals (revenue, EBITDA, margins, balance sheet), valuation (EBITDA multiples, price to sales, discounted cash flow), and thematic drivers (regulatory catalysts, state market share, capital structure). CIN publishes daily briefs, weekly chart books, and long-form thematic research covering all 494 tickers in the global cannabis universe.
Who covers cannabis stocks on the sell side?
Cannabis stocks are covered by a mix of boutique research shops (Cantor Fitzgerald, Roth Capital, Beacon Securities, Alliance Global Partners, Zuanic and Associates, ATB Capital Markets) and larger banks that have specialty analysts (Jefferies, Stifel). Coverage is thinner than for large-cap sectors because most cannabis stocks list on OTC and CSE. CIN aggregates every rating and price target on the analyst coverage page.
What metrics matter for cannabis stock analysis?
For US MSOs: adjusted EBITDA, EBITDA margin, revenue growth, retail unit economics, state-market share, and cash on hand relative to Section 280E tax liability. For Canadian LPs: gross margin, cultivation cost per gram, recreational versus medical mix, international export revenue, and cash burn. Common cross-sector metrics: revenue growth, EV/EBITDA multiples, and free cash flow.
How often does CIN publish cannabis market analysis?
Daily briefs at open, midday, and close cover same-day catalysts and price moves. The weekly chart book publishes every Monday morning with sector medians, regional performance, top movers, and methodology. Long-form thematic research runs in the Insights section on a weekly to biweekly cadence. Sector outlook and forward-view Future Lens reports publish monthly to quarterly.
Is CIN cannabis research free?
Yes. All CIN briefs, insights, chart books, and reference data are free to read on cannabisinvestornews.co. The daily brief is also delivered free to email subscribers. CIN operates as open editorial infrastructure for the cannabis capital markets and asks only for attribution when our data or analysis is cited.
How does CIN source cannabis stock data?
Prices flow from EODHD (end-of-day historical data), Finnhub, and FMP. Analyst ratings and consensus flow from Finnhub. Financial statements come from SEC EDGAR filings and SEDAR filings for Canadian issuers. The 494-ticker universe is CIN-maintained and versioned. Full methodology is at cannabisinvestornews.co/methodology.
Related coverage
Every CIN coverage module in one grid. Each is its own destination with live data and daily updates from the CIN Research Desk.